LOCALLY ADVANCED UNRESECTABLE OR METASTATIC SOLID TUMORS
Clinical trials for LOCALLY ADVANCED UNRESECTABLE OR METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED UNRESECTABLE OR METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED UNRESECTABLE OR METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Hard-to-Treat cancers by homing in on a specific protein
Disease control Recruiting nowThis study tests an experimental drug called SG1906 in people with advanced solid tumors that have a specific protein (CLDN18.2) on their surface. The trial has two parts: first, finding the safest dose, and then checking for early signs that the drug can shrink tumors. About 60 …
Matched conditions: LOCALLY ADVANCED UNRESECTABLE OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Hangzhou Sumgen Biotech Co., Ltd. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New drug combo aims to tackle Hard-to-Treat HER2 cancers
Disease control Recruiting nowThis Phase 2 trial is testing two experimental drugs (SSGJ-705 and SSGJ-612) with or without chemotherapy in 150 adults with advanced HER2-positive solid tumors, including colorectal, bladder, breast, bile duct, and stomach cancers. The goal is to see if the combination can shrin…
Matched conditions: LOCALLY ADVANCED UNRESECTABLE OR METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New drug aims to shrink hard-to-treat tumors
Disease control Recruiting nowThis study tests an experimental drug called NEOK002 in people with advanced solid tumors that have spread and cannot be removed by surgery. The drug is designed to target two proteins on cancer cells to deliver a toxic payload. The study has two parts: first, finding the safest …
Matched conditions: LOCALLY ADVANCED UNRESECTABLE OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: NEOK Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug NEOK001 targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis early-phase trial tests a new drug called NEOK001 in people with advanced solid tumors that have stopped responding to standard treatments. NEOK001 is designed to deliver a cancer-killing agent directly to tumor cells by targeting two specific proteins. The study will first …
Matched conditions: LOCALLY ADVANCED UNRESECTABLE OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: NEOK Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New drug IBI343 takes on advanced cancers in first human trial
Disease control Recruiting nowThis early-phase study tests a new drug called IBI343 in people with advanced solid tumors that cannot be removed by surgery or have spread. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. About 470 participants will take part in mul…
Matched conditions: LOCALLY ADVANCED UNRESECTABLE OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC